(FM) Oncología
Departamento académico
Carmen
Guillén Ponce
Publicaciones en las que colabora con Carmen Guillén Ponce (5)
2021
-
Motixafortide and pembrolizumab combined to nanoliposomal irinotecan, fluorouracil, and folinic acid in metastatic pancreatic cancer: The COMBAT/ KEYNOTE-202 trial
Clinical Cancer Research, Vol. 27, Núm. 18, pp. 5020-5027
2019
-
Author Correction: Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer (Scientific Reports, (2019), 9, 1, (2589), 10.1038/s41598-019-39291-2)
Scientific Reports
-
Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer
Scientific Reports, Vol. 9, Núm. 1
2013
-
Multidisciplinary management of locally advanced-borderline resectable adenocarcinoma of the head of the pancreas
Clinical and Translational Oncology, Vol. 15, Núm. 3, pp. 173-181
2007
-
Long-term outcome of a phase II study of weekly docetaxel with a short course of estramustine and enoxaparine in hormone-resistant prostate cancer patients
Clinical and Translational Oncology, Vol. 9, Núm. 5, pp. 323-328